Galmed Pharmaceuticals Ltd.

NasdaqCM:GLMD Stok Raporu

Piyasa değeri: US$4.9m

Galmed Pharmaceuticals Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Allen Baharaff

İcra Kurulu Başkanı

US$1.4m

Toplam tazminat

CEO maaş yüzdesi40.6%
CEO görev süresi24.8yrs
CEO sahipliğin/a
Yönetim ortalama görev süresi7.7yrs
Yönetim Kurulu ortalama görev süresi8.9yrs

Son yönetim güncellemeleri

Recent updates

Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Deliver On Growth Plans?

May 16
Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Deliver On Growth Plans?

Can Galmed Pharmaceuticals (NASDAQ:GLMD) Afford To Invest In Growth?

Jan 06
Can Galmed Pharmaceuticals (NASDAQ:GLMD) Afford To Invest In Growth?

Galmed GAAP EPS of -$0.15 beats by $0.09

Aug 04

Companies Like Galmed Pharmaceuticals (NASDAQ:GLMD) Could Be Quite Risky

May 03
Companies Like Galmed Pharmaceuticals (NASDAQ:GLMD) Could Be Quite Risky

Can Galmed Pharmaceuticals (NASDAQ:GLMD) Afford To Invest In Growth?

Jan 15
Can Galmed Pharmaceuticals (NASDAQ:GLMD) Afford To Invest In Growth?

Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Deliver On Growth Plans?

Oct 02
Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Deliver On Growth Plans?

Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Invest In Growth?

May 20
Is Galmed Pharmaceuticals (NASDAQ:GLMD) In A Good Position To Invest In Growth?

Galmed gets greenlight for late-stage Aramchol NASH trial in China

May 03

What Type Of Shareholders Own The Most Number of Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Shares?

Feb 04
What Type Of Shareholders Own The Most Number of Galmed Pharmaceuticals Ltd. (NASDAQ:GLMD) Shares?

We Think Galmed Pharmaceuticals (NASDAQ:GLMD) Can Afford To Drive Business Growth

Dec 06
We Think Galmed Pharmaceuticals (NASDAQ:GLMD) Can Afford To Drive Business Growth

Galmed EPS misses by $0.02

Nov 12

CEO Tazminat Analizi

Allen Baharaff'un ücretlendirmesi Galmed Pharmaceuticals'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$6m

Mar 31 2024n/an/a

-US$6m

Dec 31 2023US$1mUS$551k

-US$7m

Sep 30 2023n/an/a

-US$8m

Jun 30 2023n/an/a

-US$11m

Mar 31 2023n/an/a

-US$14m

Dec 31 2022US$1mUS$605k

-US$18m

Sep 30 2022n/an/a

-US$23m

Jun 30 2022n/an/a

-US$25m

Mar 31 2022n/an/a

-US$30m

Dec 31 2021US$3mUS$632k

-US$32m

Sep 30 2021n/an/a

-US$35m

Jun 30 2021n/an/a

-US$34m

Mar 31 2021n/an/a

-US$32m

Dec 31 2020US$1mUS$503k

-US$29m

Sep 30 2020n/an/a

-US$27m

Jun 30 2020n/an/a

-US$24m

Mar 31 2020n/an/a

-US$23m

Dec 31 2019US$1mUS$486k

-US$20m

Sep 30 2019n/an/a

-US$16m

Jun 30 2019n/an/a

-US$12m

Mar 31 2019n/an/a

-US$11m

Dec 31 2018US$2mUS$384k

-US$10m

Sep 30 2018n/an/a

-US$10m

Jun 30 2018n/an/a

-US$12m

Mar 31 2018n/an/a

-US$12m

Dec 31 2017US$1mUS$384k

-US$12m

Tazminat ve Piyasa: Allen 'nin toplam tazminatı ($USD 1.36M ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın üzerindedir ($USD 653.78K ).

Tazminat ve Kazançlar: Allen 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Allen Baharaff (59 yo)

24.8yrs

Görev süresi

US$1,356,184

Tazminat

Mr. Allen Baharaff has been the Chief Executive Officer of Galmed Pharmaceuticals Ltd. since January 2012 and has been its President since March 2015. Mr. Baharaff co-founded the Galmed Pharmaceuticals Ltd...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Allen Baharaff
Co-Founder24.8yrsUS$1.36mVeri yok
Doron Cohen
Chief Financial Officer2.8yrsUS$273.81k0.0011%
$ 55.2
Guy Nehemya
COO & Data Protection Officer7.7yrsUS$374.78k0.0021%
$ 100.6
Yohai Stenzler
Chief Accounting Officer2.8yrsUS$378.32k0.0021%
$ 100.6
Liat Hayardeny
Chief Scientific Officer8.2yrsUS$114.69k0%
$ 0
Tali Gorfine
Medical Consultant7.7yrsUS$382.51kVeri yok

7.7yrs

Ortalama Görev Süresi

55.5yo

Ortalama Yaş

Deneyimli Yönetim: GLMD 'un yönetim ekibi deneyimli ve deneyimlidir ( 7.7 yıldır).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Allen Baharaff
Co-Founderno dataUS$1.36mVeri yok
David Sidransky
Lead Independent Director10.4yrsVeri yok0.0028%
$ 136.2
Carol Brosgart
Independent Director7.4yrsVeri yok0%
$ 0
José Mato de la Paz
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Scott L. Friedman
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Arun Sanyal
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Vlad Ratziu
Member of Scientific Advisory Boardno dataVeri yokVeri yok
Shmuel Nir
Independent Director17.8yrsVeri yok0.0028%
$ 136.2
Amir Poshinski
Independent Director4.4yrsVeri yok0%
$ 0
Shomron Ben-Horin
Member of Scientific Advisory Boardno dataVeri yokVeri yok

8.9yrs

Ortalama Görev Süresi

63yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: GLMD 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 8.9 yıldır).